[go: up one dir, main page]

GB8819453D0 - Production of bluetongue virus non-structural proteins using baculovirus expression vector - Google Patents

Production of bluetongue virus non-structural proteins using baculovirus expression vector

Info

Publication number
GB8819453D0
GB8819453D0 GB888819453A GB8819453A GB8819453D0 GB 8819453 D0 GB8819453 D0 GB 8819453D0 GB 888819453 A GB888819453 A GB 888819453A GB 8819453 A GB8819453 A GB 8819453A GB 8819453 D0 GB8819453 D0 GB 8819453D0
Authority
GB
United Kingdom
Prior art keywords
production
expression vector
structural proteins
baculovirus expression
bluetongue virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888819453A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROY P
Original Assignee
ROY P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROY P filed Critical ROY P
Priority to GB888819453A priority Critical patent/GB8819453D0/en
Publication of GB8819453D0 publication Critical patent/GB8819453D0/en
Priority to EP89909839A priority patent/EP0431038A1/en
Priority to PCT/GB1989/000939 priority patent/WO1990002186A1/en
Priority to ZA896202A priority patent/ZA896202B/en
Priority to AU41988/89A priority patent/AU4198889A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB888819453A 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector Pending GB8819453D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB888819453A GB8819453D0 (en) 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector
EP89909839A EP0431038A1 (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector
PCT/GB1989/000939 WO1990002186A1 (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector
ZA896202A ZA896202B (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector
AU41988/89A AU4198889A (en) 1988-08-16 1989-08-15 Production of bluetongue virus non-structural proteins using a baculovirus expression vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819453A GB8819453D0 (en) 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector

Publications (1)

Publication Number Publication Date
GB8819453D0 true GB8819453D0 (en) 1988-09-21

Family

ID=10642209

Family Applications (1)

Application Number Title Priority Date Filing Date
GB888819453A Pending GB8819453D0 (en) 1988-08-16 1988-08-16 Production of bluetongue virus non-structural proteins using baculovirus expression vector

Country Status (5)

Country Link
EP (1) EP0431038A1 (en)
AU (1) AU4198889A (en)
GB (1) GB8819453D0 (en)
WO (1) WO1990002186A1 (en)
ZA (1) ZA896202B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026254A2 (en) * 2000-09-27 2002-04-04 The Uab Research Foundation Non-replicative particulate vaccine delivery system and methods of making and using same
JP2007519422A (en) 2004-02-02 2007-07-19 アンブレツクス・インコーポレイテツド Modified human four helix bundle polypeptides and their use
EP1771205B1 (en) 2004-06-18 2016-10-26 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
BRPI0512396A (en) 2004-07-21 2008-03-11 Ambrx Inc biosynthetic polypeptides using non-naturally encoded amino acids
US7736872B2 (en) 2004-12-22 2010-06-15 Ambrx, Inc. Compositions of aminoacyl-TRNA synthetase and uses thereof
CA2590462C (en) 2004-12-22 2017-02-28 Ambrx, Inc. Methods for expression and purification of recombinant human growth hormone
ATE542920T1 (en) 2004-12-22 2012-02-15 Ambrx Inc MODIFIED HUMAN GROWTH HORMONE
EP1833993A4 (en) 2004-12-22 2009-07-22 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
CA2927595C (en) 2004-12-22 2023-01-31 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
AU2006255122B2 (en) 2005-06-03 2010-10-21 Ambrx, Inc. Improved human interferon molecules and their uses
DK1937824T3 (en) 2005-08-18 2013-04-02 Ambrx Inc Compositions of tRNA and uses thereof
JP2009520949A (en) 2005-11-16 2009-05-28 アンブルックス，インコーポレイテッド Compositions and methods containing unnatural amino acids
AU2007292903B2 (en) 2006-09-08 2012-03-29 Ambrx, Inc. Modified human plasma polypeptide or Fc scaffolds and their uses
SG174788A1 (en) 2006-09-08 2011-10-28 Ambrx Inc Suppressor trna transcription in vertebrate cells
DK2061878T3 (en) 2006-09-08 2014-04-07 Ambrx Inc HYBRID SUPPRESSOR TRNA FOR ANIMAL CELLS
JP2010523084A (en) 2007-03-30 2010-07-15 アンブルックス，インコーポレイテッド Modified FGF-21 polypeptide
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
DK2217265T3 (en) 2007-11-20 2017-07-03 Ambrx Inc Modified insulin polypeptides and their use
US9938333B2 (en) 2008-02-08 2018-04-10 Ambrx, Inc. Modified leptin polypeptides and their uses
MX2011000859A (en) 2008-07-23 2011-02-24 Ambrx Inc Modified bovine g-csf polypeptides and their uses.
EA019653B1 (en) 2008-09-26 2014-05-30 Амбркс Инк. Modified animal erythropoietin polypeptides and their uses
PL2337846T3 (en) 2008-09-26 2018-06-29 Ambrx, Inc. Non-natural amino acid replication-dependent microorganisms and vaccines
EP2805965A1 (en) 2009-12-21 2014-11-26 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
US20120283171A1 (en) 2009-12-21 2012-11-08 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
CA2808596C (en) 2010-08-17 2020-12-15 Ambrx, Inc. Modified relaxin polypeptides and their uses
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (en) 2010-09-23 2015-04-11 Lilly Co Eli Formulations for bovine granulocyte colony stimulating factor and variants thereof
CN114805531A (en) 2014-10-24 2022-07-29 百时美施贵宝公司 Modified FGF-21 polypeptides and uses thereof
KR102670432B1 (en) 2017-02-08 2024-05-28 브리스톨-마이어스 스큅 컴퍼니 Modified relaxin polypeptides containing pharmacokinetic enhancers and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591459B2 (en) * 1984-08-31 1989-12-07 Research Corporation cDNA probe for the detection of bluetongue virus
AP114A (en) * 1987-02-19 1991-02-01 Oxford Virology Ltd Production of bluetongue virus antigens using a baculovirus expression vector.

Also Published As

Publication number Publication date
EP0431038A1 (en) 1991-06-12
ZA896202B (en) 1990-08-29
WO1990002186A1 (en) 1990-03-08
AU4198889A (en) 1990-03-23

Similar Documents

Publication Publication Date Title
GB8819453D0 (en) Production of bluetongue virus non-structural proteins using baculovirus expression vector
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
GB8610551D0 (en) Polypeptide & protein derivatives
NO180362C (en) Process for the preparation of cyclosporin-containing preparations
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
AU3756789A (en) Antagonists of viral transactivating proteins
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
ZA891355B (en) Expression of hiv binding proteins
ZA875633B (en) Recombinant htlv-iii proteins and uses thereof
AP8800083A0 (en) Production of bluetongue virus antigens using a baculovirus expression vector
AU5567090A (en) Purification of proteins employing ctap-iii fusions
ZA895460B (en) Novel proteins
IL86153A0 (en) Recombinant htlv-iii proteins and uses thereof
YU219289A (en) Recombinant hybride proteins of interleucine-2
ZA895461B (en) Modified proteins
GB2193206B (en) Preparation of taurine-containing peptides
IE883483L (en) Expression of hiv proteins
PT86162A (en) Recombinant protein expression
EP0323846A3 (en) Process of preparing thiamphenicol
IE894106L (en) Expression of the plasmodium circumsporozite protein in¹insects
IE881525L (en) Preparation of protein
IE881482L (en) Recombinant htlv-iii proteins
GB8608182D0 (en) Production of proteins
ZA88849B (en) Production of bluetongue virus antigens using a baculovirus expression vector
ZA893263B (en) Production of polypeptides